ImmunityBio, Inc.
ImmunityBio, Inc.（IBRX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · IBRX · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
9
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
ImmunityBio, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
IBRX 季度内部人买卖趋势
IBRX 内幕交易卖出 · IBRX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · IBRX CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
IBRX 高管卖出股份 · IBRX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 4, 2026 | Simon Barry J. Director | Sale | 23,033 | $165K | Form 4 |
| Mar 31, 2026 | SOON-SHIONG PATRICK See remarks · Director | Other | 4,606,596 | $25.00M⚡ | Form 4 |
| Feb 24, 2026 | Simon Barry J. Director | Sale | 75,000 | $901K | Form 4 |
| Feb 23, 2026 | Selecky Christobel Director | Option | 25,000 | $75K | Form 4 |
| Feb 23, 2026 | Selecky Christobel Director | Sale | 25,000 | $250K | Form 4 |
| Feb 22, 2026 | Sachs David C. CFO | Option | 40,650 | — | Form 4 |
| Feb 22, 2026 | Sachs David C. CFO | Other | 20,682 | $180K | Form 4 |
| Feb 22, 2026 | SOON-SHIONG PATRICK See remarks · Director | Option | 114,329 | — | Form 4 |
| Feb 22, 2026 | SOON-SHIONG PATRICK See remarks · Director | Other | 58,170 | $506K | Form 4 |
| Feb 22, 2026 | LAUER REGAN J CAO | Option | 4,065 | — | Form 4 |
| Feb 22, 2026 | LAUER REGAN J CAO | Other | 1,673 | $15K | Form 4 |
| Feb 22, 2026 | Adcock Richard CEO & President · Director | Option | 152,439 | — | Form 4 |
| Feb 22, 2026 | Adcock Richard CEO & President · Director | Other | 77,560 | $675K | Form 4 |
| Feb 22, 2026 | Simon Barry J. Director | Option | 15,243 | — | Form 4 |
| Feb 22, 2026 | Simon Barry J. Director | Other | 6,026 | $52K | Form 4 |
| Feb 20, 2026 | Simon Barry J. Director | Sale | 10,000 | $93K | Form 4 |
| Feb 23, 2026 | Simon Barry J. Director | Sale | 165,000 | $1.69M⚡ | Form 4 |
| Feb 10, 2026 | SOON-SHIONG PATRICK See remarks · Director | Option | 274,122 | — | Form 4 |
| Feb 10, 2026 | SOON-SHIONG PATRICK See remarks · Director | Other | 118,560 | $822K | Form 4 |
| Feb 10, 2026 | Sachs David C. CFO | Option | 82,236 | — | Form 4 |
| Feb 10, 2026 | Sachs David C. CFO | Other | 42,643 | $296K | Form 4 |
| Feb 10, 2026 | LAUER REGAN J CAO | Option | 5,482 | — | Form 4 |
| Feb 10, 2026 | LAUER REGAN J CAO | Other | 2,257 | $16K | Form 4 |
| Feb 10, 2026 | Adcock Richard CEO & President · Director | Option | 274,122 | — | Form 4 |
| Feb 10, 2026 | Adcock Richard CEO & President · Director | Other | 140,048 | $971K | Form 4 |
SOON-SHIONG PATRICK
See remarks · Director
日期
Mar 31
股数
4,606,596
均价
$5.43
总金额
$25.00M ⚡
SOON-SHIONG PATRICK
See remarks · Director
日期
Feb 10
股数
118,560
均价
$6.93
总金额
$822K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 IBRX 内幕交易
IBRX 内幕交易
ImmunityBio, Inc.（IBRX）内幕交易数据来源于公司内部人（包括Simon Barry J. (Director), Selecky Christobel (Director), Sachs David C. (CFO)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。IBRX内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看ImmunityBio, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
IBRX 内幕交易 · 5个问题ImmunityBio, Inc.（IBRX）的内部人包括高管和董事，如Simon Barry J. (Director), Selecky Christobel (Director), Sachs David C. (CFO)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026